Showing results (111-120 of 295) with videos related to
Sort By:
Pageof 30
Clinical Therapeutics|September 4, 2012
Efficacy and tolerability of linagliptin added to a sulfonylurea regimen in patients with inadequately controlled type 2 diabetes mellitus: an 18-week, multicenter, randomized, double-blind, placebo-controlled trialAndrew J Lewin, Lisa Arvay, Dacheng Liu, et al.Cancer|October 12, 2010
Short duration of sleep increases risk of colorectal adenomaCheryl L Thompson, Emma K Larkin, Sanjay Patel, et al.Clinical Endocrinology|April 18, 2007
Characteristics of cardiac and vascular structure and function in Prader-Willi syndromeSanjay Patel, Jason A Harmer, Georgina Loughnan, et al.American Heart Journal|July 9, 2019
The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarctionThomas Hennessy, Linda Soh, Mitchell Bowman, et al.The Pediatric Infectious Disease Journal|April 4, 2018
The Impact of Pediatric Outpatient Parenteral Antibiotic Therapy Implementation at a Tertiary Children's Hospital in the United KingdomSanjay Patel, Valentina Burzio, Helen Green, et al.Lancet (London, England)|August 17, 2013
Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trialAnthony H Barnett, Holger Huisman, Russell Jones, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 12, 2020
Digital interventions for parents of acutely ill children and their treatment-seeking behaviour: a systematic reviewEmily Donovan, Christopher R Wilcox, Sanjay Patel, et al.European Journal of Preventive Cardiology|May 16, 2025
The efficacy and safety of low dose colchicine in atherosclerotic cardiovascular disease - A systematic review and meta-analysisBradley Tucker, William J Tucker, Ji Soo Chung, et al.Diabetes & Vascular Disease Research|May 19, 2016
Linagliptin and pioglitazone combination therapy versus monotherapy with linagliptin or pioglitazone: A randomised, double-blind, parallel-group, multinational clinical trialMichael Albrecht Nauck, Maximiliano di Domenico, Sanjay Patel, et al.Clinical Pharmacokinetics|February 1, 2015
Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes MellitusSilke Retlich, Vincent Duval, Ulrike Graefe-Mody, et al.Pageof 30